H-2M3a violates the paradigm for major histocompatibility complex class I peptide binding

Area of Science:

• Immunology
• Molecular Biology
• Structural Biology

Background:

• Major histocompatibility (MHC) class I-b molecule H-2M3a presents N-formylated peptides to cytotoxic T lymphocytes.
• This binding specificity may limit the repertoire of peptides presented by H-2M3a.
• The M3a-Ld MHC class I chimera is typically expressed at low levels but can be upregulated by specific peptides.

Purpose of the Study:

• To investigate the peptide binding characteristics of the H-2M3a molecule.
• To determine the minimum and optimal peptide lengths for H-2M3a binding and stabilization.
• To explore the implications of H-2M3a's binding flexibility for immune system surveillance.

Main Methods:

• Utilized a peptide stabilization assay involving the M3a-Ld MHC class I chimera.
• Assessed peptide binding by measuring the induction of cell surface expression at 27 degrees C.
• Employed temperature shift experiments (27-37 degrees C) to evaluate peptide-MHC complex stability.

Main Results:

• H-2M3a binds a variety of very short N-formyl peptides, including chemotactic peptides and octapeptides.
• Peptide binding and stabilization were observed with N-formyl peptides as short as two amino acids.
• Increasing peptide length enhanced the stability of peptide-MHC complexes.
• Stabilization was detectable at low peptide concentrations (100 nM).

Conclusions:

• H-2M3a exhibits a relaxed peptide length-binding rule compared to typical MHC class I molecules.
• This flexibility in binding short peptides may be an adaptation to increase the diversity of antigens presented.
• The findings expand our understanding of antigen processing and presentation by MHC class I-b molecules.